Haas, Tobias Longin
 Distribuzione geografica
Continente #
NA - Nord America 1.194
EU - Europa 889
AS - Asia 445
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.532
Nazione #
US - Stati Uniti d'America 1.189
SE - Svezia 315
CN - Cina 264
IT - Italia 157
PL - Polonia 129
SG - Singapore 92
IE - Irlanda 68
DE - Germania 45
ID - Indonesia 41
FR - Francia 29
FI - Finlandia 27
UA - Ucraina 27
RU - Federazione Russa 21
GB - Regno Unito 20
TR - Turchia 18
ES - Italia 17
BE - Belgio 12
IN - India 12
NL - Olanda 12
AT - Austria 6
VN - Vietnam 6
HK - Hong Kong 4
CA - Canada 3
BR - Brasile 2
CH - Svizzera 2
IR - Iran 2
JP - Giappone 2
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
LK - Sri Lanka 1
PK - Pakistan 1
PR - Porto Rico 1
TW - Taiwan 1
Totale 2.532
Città #
Chandler 175
Ashburn 153
Warsaw 129
Fairfield 99
Singapore 69
Dublin 68
Nanjing 61
Dearborn 56
Wilmington 52
Houston 45
Ann Arbor 41
Jakarta 41
Redmond 39
Princeton 38
Woodbridge 38
Cambridge 35
Jacksonville 34
Seattle 33
Cattolica 32
Rome 32
San Mateo 30
Helsinki 24
Los Angeles 21
Nanchang 21
Falkenstein 20
Kunming 19
Beijing 17
Shenyang 17
Hebei 15
Izmir 15
Redwood City 15
Boston 14
Brussels 12
Moscow 12
New York 12
Shanghai 12
Donostia / San Sebastian 11
Chicago 10
Changsha 9
Tianjin 9
Washington 9
Guangzhou 8
Hefei 8
Hangzhou 7
Milan 7
Mountain View 7
Norwalk 7
Dong Ket 6
San Diego 6
Vienna 6
Bremen 5
London 5
Marseille 5
Santa Clara 5
Turin 5
Andover 4
Changchun 4
Falls Church 4
Gurgaon 4
Hong Kong 4
Sangüesa 4
Augusta 3
Boardman 3
Fuzhou 3
Genoa 3
Jiaxing 3
Lanzhou 3
Paris 3
Zhengzhou 3
Catanzaro 2
Changshahsien 2
Chiswick 2
Crick 2
Edinburgh 2
Fort Worth 2
Frankfurt am Main 2
Genova 2
Groningen 2
Gualdo Cattaneo 2
Harbin 2
Kocaeli 2
Madrid 2
Pace del Mela 2
Phoenix 2
Salò 2
San Francisco 2
San Jose 2
Toronto 2
Turku 2
Verona 2
Wuhan 2
Zurich 2
Acton 1
Amsterdam 1
Baghdad 1
Benevento 1
Bergamo 1
Brindisi 1
Chaoyang 1
Chengdu 1
Totale 1.783
Nome #
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 257
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 245
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 142
Inhibitor of integrin for the treatment or prevention of tumours 134
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 109
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 98
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 98
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 88
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 88
Two-Step Co-Immunoprecipitation (TIP) 88
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L 71
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 67
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 62
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex 57
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 56
Lung cancer stem cells: Tools and targets to fight lung cancer 54
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 52
The linear ubiquitin chain assembly complex (LUBAC) forms part of the TNF-R1 signalling complex and is required for effective TNF-induced gene induction and prevents TNF-induced apoptosis 50
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling 48
Linear ubiquitination prevents inflammation and regulates immune signalling 48
Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts 44
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 43
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 43
Biochemical analysis of the native TRAIL death-inducing signaling complex 38
Polymeric substrates with tunable elasticity and nanoscopically controlled biomolecule presentation 38
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects 38
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis 36
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction 33
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway 33
Small molecule XIAP inhibitors enhance TRAIL-Lnduced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma 32
Regulation of Enterocyte Apoptosis by Acyl-CoA Synthetase 5 Splicing 31
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo 30
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window 29
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis 28
NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2 28
Biochemical analysis of the native TRAIL death-inducing signaling complex 28
Enhanced caspase-8 recruitment to and activation at the disc is critical for sensitisation of human hepatocellular carcinoma cells to trail-induced apoptosis by chemotherapeutic drugs 27
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors 26
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL 25
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs 24
Micro-nanostructured protein arrays: a tool for geometrically controlled ligand presentation 24
Totale 2.590
Categoria #
all - tutte 13.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 58 58 18 24 11 45 14
2020/2021186 12 13 24 8 36 11 18 5 14 15 20 10
2021/2022295 22 15 7 14 29 33 5 54 14 24 49 29
2022/2023645 124 102 65 58 59 67 25 44 61 11 18 11
2023/2024389 10 98 16 44 13 49 18 11 3 33 49 45
2024/2025230 22 20 68 25 42 53 0 0 0 0 0 0
Totale 2.590